Have Thoracic Endografting Outcomes Improved Since FDA Approval?

OBJECTIVE: Thoracic endovascular aneurysm repair (TEVAR) is gaining acceptance since Food and Drug Administration approval in 2005. We hypothesize that, compared to open repair (OPEN), mortality and complication rate after TEVAR have continued to improve. METHODS: All patients who underwent thoracic...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bhamidipati, Castigliano M, LaPar, Damien J, Mehta, Gaurav S, Kern, John A, Kron, Irving L, Upchurch, Gilbert R, Ailawadi, Gorav
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3086831/
https://ncbi.nlm.nih.gov/pubmed/21439547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2011.01.037
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares